Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst / Investor Meet with Premji Invest and Alchemy Capital on 15-Feb-202109-02-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst / Investor Meet with Premji Invest and Alchemy Capital on 15-Feb-2021Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Details of Investor Conferences the Company plan to attend during the month of February 2021: Edelweiss India Annual e-Conference 2021 on Feb 9, 2021 and IIFL Securities - Global Investor Conference on Feb 25, 2021Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Video/Tele - Conference - One on One with Nomura Asset Management on 17th February 2021Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Tele/Video Conference - One on One meeting with Neuberger Berman Group LLC on 12-Feb-2021Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst / Investor Meet with Nippon India Mutual Fund and Pictet Asset Management UK Ltd. on 10-Feb-2021 and 11-Feb-2021Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Tele/Video Conference - One on One meeting with Capital Research Global Investors on 10-Feb-2021Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Tele/Video Conference - One on One meeting with Government Of Singapore on 3-Feb-2021Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Tele/Video Conference - One on One with Goldman Sachs India SPL on 4-Feb-2021Gland Pharma Q3: Strong and clean play on global generic injectables; accumulate
We believe dominance of profit/royalty-sharing aspect in the business model distinguishes Gland Pharma from other contract manufacturersEarnings Call for Q3FY21 of Gland Pharma
Conference Call with Gland Pharma Management and Analysts on Q3FY21 Performance and Outlook. Listen to the full earnings transcript.